Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1 β Axis in Microglia
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Sepsis-associated encephalopathy (SAE) is characterized as brain dysfunction associated with sepsis. In this study we sought to investigate the effects of resveratrol in mice with SAE, as well as its effects in NLRP3 inflammasome and IL-1 β, which were critical in the pathogenesis of SAE. SAE was induced in mice via cecal ligation and puncture (CLP), and resveratrol was administered at two doses after surgery. Spatial learning memory functions were evaluated by Morris water maze testing. Apoptosis in the hippocampus was quantified using TUNEL assay. Inflammation in the hippocampus was quantified by measuring the levels of microglial activation, NLRP3, and IL-1 β. CLP mice treated with resveratrol demonstrated a better spatial memory during water maze training. The TUNEL assay demonstrated significantly attenuated rates of apoptosis, in resveratrol treated mice, while decreasing the number of iba-1 positive microglia in the hippocampus region. NLRP3 expression and IL-1 β cleavage were well inhibited by resveratrol dose-dependently. The in vitro results showed that in the BV2 cell lines resveratrol prevents ATP induced NLRP3 activation and IL-1 β cleavage, which were reversed by the sirtuin 1 inhibitor, nicotinamide. In conclusion, resveratrol improves the spatial memory in mice with SAE and inhibits the NLRP3/IL-1 β axis in the microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, SIRT1 activation by Resveratrol prevented NLRP3 expression and IL-1β cleavage in hippocampus of mice with sepsis-associated encephalopathy (64).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 1×
“NLRP3/caspase-1 axis played a central role in the pathogenesis of Alzheimer’s disease [28].”
BackgroundMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Iba-1 is a marker of activation for microglia [17].”
BackgroundMicroglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“The accumulation of amyloidβ can activate NLRP3 in microglia, while the increased maturation of IL-1β further hampered the clearance of amyloidβ by microglia [29].”
BackgroundWang, Y., Xu, C.-F., Liu, Y.-J., Mao, Y.-F., Lv, Z., Li, S.-Y., Zhu, X.-Y., & Jiang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477112 · Cited by 825
Sepsis-associated encephalopathy
Gofton, T. E., & Young, G. B. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.183 · Cited by 821 · cited 1×
“During this response, multiple organ failure has the potential to be elicited, where manifestation of brain dysfunction during sepsis can lead to sepsis-associated encephalopathy (SAE) [2, 3].”
BackgroundHenry, C. J., Huang, Y., Wynne, A. M., & Godbout, J. P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.002 · Cited by 565 · cited 1×
“Another study showed that IL-1β expression was increased by the microglia of aged mice that were challengedwith peripheral LPS administration [27].”
BackgroundWitte, A. V., Kerti, L., Margulies, D. S., & Floel, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0385-14.2014 · Cited by 455 · cited 1×
“But most importantly, in humans, a controlled randomized, pair-matched, placebocontrolled trial showed that continuous intake of resveratrol for a period of 26 weeks showed improvements in memory performance, which included memory retention, delayed recall, recognition, learning ability, and fifth learning trial [25].”
BackgroundNeuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F., Wu, Q., Lu, Y.-F., Gong, Q.-H., & Shi, J.-S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384 · cited 1×
“In another common neurodegenerative disease, Parkinson’s disease, resveratrol was able to increase themotor coordination skills in rat models [24].”
BackgroundResveratrol as a Therapeutic Agent for Neurodegenerative Diseases
Sun, A. Y., Wang, Q., Simonyi, A., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8111-y · Cited by 329 · cited 1×
“Additional studies regarding the neuroprotective effect were focused on exploring the antiaging and antineurodegerative effect [14, 22].”
Background
Research works printed but not linked: 3
- 2012, Translational Medicine @ UniSa, 2, 20
- 10.3760/cma.j.issn.0366-6999.2012.05.018 · doi:10.3760/cma.j.issn.0366-6999.2012.05.018
- 2014, Current Neurovascular Research, 11, 263
Cited by
Items 101–101 of 101
Li, H., Liao, H., Sun, L., Chen, D., Fei, Y., Yao, M., Huang, B., Guo, X., Song, S., & Bao, H. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2307140 · Cited by 6
“In particular, microglial cells participate in the process of generating inflammatory factors and eliminating ACs in SAE rats [ 30].”
Background
Metadata
- Authors
- Sui, D.-M., Xie, Q., Yi, W.-J., Gupta, S., Yu, X.-Y., Li, J.-B., Wang, J., Wang, J.-F., & Deng, X.-M.
- Affiliations
- Department of Anesthesiology and Intensive Care, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, China
- Second Military Medical University (CN)
- St. Michael's Hospital (CA)
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-10
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4746398
- OpenAlex
- W2260882979
- Cited by
- 124
- References
- 37
- Citations by year
- 2025: 8 · 2024: 9 · 2023: 18 · 2022: 16 · 2021: 24 · 2020: 18 · 2019: 10 · 2018: 8 · 2017: 5 · 2016: 7
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81571935, 81272065)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- resveratrol, sepsis-associated encephalopathy, NLRP3 inflammasome, IL-1β, microglia, hippocampal apoptosis, spatial memory, cecal ligation and puncture, SIRT1, nicotinamide, neuroprotection, BV2 microglial cells
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Resveratrol, Animals, Cell Line, Male, Mice, Inbred C57BL, Stilbenes, Microglia, Mice, Interleukin-1beta, Sepsis-Associated Encephalopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.